West Pharmaceutical Services Inc (WST)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 3,829,500 3,754,700 3,669,600 3,723,600 3,616,800 3,316,800 3,361,700 3,294,700 3,313,800 3,142,600 2,933,500 2,739,700 2,793,800 2,582,800 2,392,300 2,246,500 2,341,400 2,174,000 2,123,200 2,036,200
Total stockholders’ equity US$ in thousands 2,881,000 2,868,200 2,746,700 2,776,200 2,684,900 2,470,800 2,424,400 2,326,200 2,335,400 2,202,300 2,032,600 1,829,000 1,854,500 1,718,900 1,606,300 1,490,200 1,573,200 1,487,600 1,445,100 1,369,500
Financial leverage ratio 1.33 1.31 1.34 1.34 1.35 1.34 1.39 1.42 1.42 1.43 1.44 1.50 1.51 1.50 1.49 1.51 1.49 1.46 1.47 1.49

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $3,829,500K ÷ $2,881,000K
= 1.33

The financial leverage ratio of West Pharmaceutical Services, Inc. has been relatively stable over the past eight quarters, ranging from 1.31 to 1.42. The ratio indicates that the company's capital structure is moderately leveraged, with a slight fluctuation but no significant trend observed during the period.

A financial leverage ratio above 1 suggests that the company has more debt than equity in its capital structure, which indicates some level of financial risk. In the case of West Pharmaceutical Services, Inc., the ratios ranging from 1.31 to 1.42 demonstrate that the company relies more on debt financing compared to equity, but the extent of leverage has not shown significant variations.

It is essential for investors and stakeholders to monitor the financial leverage ratio over time to assess the company's ability to meet its financial obligations and manage its debt effectively. Any significant changes in the ratio may indicate changes in the company's capital structure and risk profile, necessitating further analysis to understand the implications for the company's financial health and stability.


Peer comparison

Dec 31, 2023

Company name
Symbol
Financial leverage ratio
West Pharmaceutical Services Inc
WST
1.33
Carlisle Companies Incorporated
CSL
2.34